A fast-growing San Francisco AI startup is now in a major copyright fight

The New York Times has filed a federal lawsuit in New York against AI startup Perplexity, alleging the company scraped and repackaged Times articles, videos and podcasts to generate AI responses that reproduce "verbatim or near-verbatim" material and sometimes attribute false information to the paper. Perplexity, a 2022-founded unicorn that has raised over $1.5 billion and offers the Comet browser and AI search tools, faces claims for damages and an injunction to remove Times content; the suit joins similar cases from Dow Jones and the Chicago Tribune. The case raises direct legal and licensing risk for generative-AI firms, could pressure valuations and product deployments for startups reliant on unlicensed news content, and underscores publishers' parallel moves to secure AI licensing deals with major tech firms.

Analysis

Market-structure: The suit is a positive shock for legacy publishers (NYT) and large cloud/IP holders (AMZN, MSFT) because a legal precedent forcing licensing would convert previously free training inputs into a recurring-cost/revenue pool; winners gain pricing power on content, losers are unlicensed AI search/aggregation players that face higher COGS and potential injunctions. Competitive dynamics favor deep-pocketed platforms that can absorb licensing (AWS, Azure, OpenAI partners) and monetize via bundled services, likely accelerating consolidation among startups and compressing valuations of high-burn, unlicensed AI search plays within 6–18 months. Supply/demand: demand for cleared/licensed training data will rise sharply, supply of low-cost scraped data falls, implying upward pressure on data licensing prices (could double for premium outlets in 12–24 months) and higher marginal costs for model owners. Cross-asset: expect modest credit spread widening for VC-backed AI firms (up to +100–200bps on stressed names), short-term equity volatility in tech indexes (XLK) and idiosyncratic upside for NYT; FX/commodities largely unaffected except for cloud-capex-sensitive hardware vendors (NVDA) which remain correlated to AI demand.

Risk assessment: Tail risks include a precedent ruling requiring industry-wide licensing or injunctions that remove core features from products—this could wipe 10–30% off valuations of pure-play AI search companies and force multi-hundred-million-dollar settlements within 12–36 months. Immediate (days) volatility will be news-driven; short-term (weeks–months) outcomes hinge on filings and countersuits; long-term (years) regime change depends on appellate rulings or regulatory standard setting. Hidden dependencies: startups’ survival depends on VC liquidity and cloud credits; plaintiffs’ wins could redirect ad/subscription revenue flows and accelerate paywalled data strategies. Catalysts to watch: preliminary injunctions, multi-publisher class actions, DOJ/FTC guidance, and high-profile settlements (NYT/Perplexity or OpenAI-type deals) — expect decisive moves within 6–12 months.

Trade implications: Tactical longs: establish 1–2% positions in NYT to capture potential licensing revenue and subscriber halo over 6–12 months, financed partially by trimming unprofitable AI/aggregation small caps; add 2–3% exposure to AMZN (AWS leverage) via 3–6 month call spreads to play enterprise licensing demand. Defensive: overweight MSFT (1.5–2%) for enterprise AI moat and buy 6–12 month protective puts on a 3–5% tech-basket sleeve to cap downside at ~10%. Relative-value pair: long NYT vs short an equal-weight basket of public AI/aggregator names (reduce that basket exposure by 50%) until legal clarity in 6–12 months; re-evaluate after any injunction or settlement. Options: buy NYT 12-month call spreads (buy LEAP, sell higher strike) to limit premium while retaining upside if licensing wins; allocate <1% portfolio to these option positions.

Contrarian angles: Consensus assumes publisher wins = broad tech sell-off; what’s missed is the likely commercial solution path — industry-wide licensing deals (music/Napster analogue) that create new B2B revenue streams for both platforms and publishers, benefiting large tech while weeding out marginal startups, so corrections in public AI names could be overdone if settlements are modest (<$100–200M aggregate). Historical parallels (music licensing) show initial litigation then rapid licensing; a mid-case outcome would favor AMZN/MSFT more than startups and create consolidation M&A opportunities at 20–40% discount to fair value. Unintended consequence: higher licensing costs will accelerate development of proprietary/synthetic corpora and partnerships, increasing moat for well-funded incumbents and making small independent models structurally unviable — favor balance-sheet rich names.

Key Decisions for Investors

• Establish a 1–2% long position in NYT over the next 30–90 days to capture potential licensing upside; hedge cost by purchasing a 12‑month NYT call spread (buy LEAP, sell higher strike) sized to 0.5–1% of portfolio; increase to 3% only if a preliminary injunction or >$50M damages award is announced.
• Allocate 2–3% to AMZN via a 3–6 month call spread to play AWS/licensing tailwinds; take profits if AMZN rallies >15% in 6 months or if public multi-publisher licensing deals are announced that explicitly name Amazon as partner.
• Reduce/underweight public small-cap AI search/aggregator and unprofitable SaaS exposure by ~50% relative to benchmark and reallocate 1.5–2% into MSFT for enterprise AI moat; if maintaining any small-cap exposure, buy 3-month puts ~10% OTM sized to 30–50% of that sleeve as protection.
• Purchase 6–12 month downside protection on the tech sleeve (e.g., XLK puts sized to cap sleeve losses at ~10%, costing ~0.5–1% of portfolio) to insure against a legal precedent that forces feature rollbacks or large settlements within 12–24 months.